Sulaiman Abdur-Rahman

November 18, 2024 | National Law Journal

The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program but also Medicaid and Medicare Part B if manufacturers implement a cash replenishment model,” counsel for Eli Lilly—the manufacturer of Mounjaro, Trulicity and other treatments for weight loss or diabetes—alleged in their complaint.

By Sulaiman Abdur-Rahman

3 minute read

November 15, 2024 | National Law Journal

Susman Godfrey partner Bill Carmody said the $266 million “verdict was an important step toward helping Baltimore recover so that it can continue to be one of the best cities in America and a place where all of its citizens can be healthy and succeed."

By Sulaiman Abdur-Rahman

3 minute read

November 14, 2024 | National Law Journal

“We’re holding them hostage,” Republican Commissioner Melissa Holyoak of the Federal Trade Commission said of merging parties affected by FTC Chair Lina Khan’s strategic use of consent orders. “This is an extreme abuse of our authority. It is so troubling to me.”

By Sulaiman Abdur-Rahman

4 minute read

November 14, 2024 | National Law Journal

“The Justice Department will not hesitate to check unlawful consolidation and monopolization in the health care market that threatens to harm vulnerable patients, their families, and health care workers,” U.S. Attorney General Merrick Garland said.

By Sulaiman Abdur-Rahman

3 minute read

November 12, 2024 | National Law Journal

April M. Perry has become President Joe Biden's 214th successful nominee, with the majority of those appointees being women or persons of color. In 2023, Vice President-elect JD Vance had opposed her nomination as U.S. attorney in Chicago.

By Sulaiman Abdur-Rahman

3 minute read

November 12, 2024 | National Law Journal

U.S. District Senior Judge Beryl A. Howell ruled that federal law “precludes the exercise of jurisdiction to review the agency’s classification of certain oral-only drugs as ‘renal dialysis services’ and its decision to identify [Ardelyx Inc.’s drug Xphozah] as qualifying for such classification.”

By Sulaiman Abdur-Rahman

4 minute read

November 11, 2024 | National Law Journal

“Although we are disappointed that the preliminary injunction was denied without prejudice and as premature, which we intend to appeal, this denial has no bearing on the merits of our case,” Winston & Strawn partner Jeffrey Kessler said in response to a U.S. District Court ruling in his NASCAR antitrust lawsuit.

By Sulaiman Abdur-Rahman

3 minute read

November 08, 2024 | National Law Journal

"Winning the election is going to make it difficult for any of these cases to get to him," Syracuse University law professor Gregory L. Germain said of President-elect Donald Trump.

By Sulaiman Abdur-Rahman

4 minute read

November 07, 2024 | National Law Journal

"We have always been adamant that the Senate must confirm all of President Biden's nominees and fill every possible vacancy, regardless of who wins the election," said Jake Faleschini, of Alliance for Justice.

By Avalon Zoppo | Sulaiman Abdur-Rahman

5 minute read

November 05, 2024 | National Law Journal

Wiley Rein partner Stephen Obermeier said U.S. District Judge Randolph Moss "made the right decision" to deny a Democratic Congressional Campaign Committee motion seeking preliminary injunctive relief in a lawsuit accusing Republicans of campaign spending violations.

By Sulaiman Abdur-Rahman

3 minute read